Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis

Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis

Kwo PY;Poordad F;Asatryan A;Wang S;Wyles DL;Hassanein T;Felizarta F;Sulkowski MS;Gane E;Maliakkal B;Overcash JS;Gordon SC;Muir AJ;Aguilar H;Agarwal K;Dore GJ;Lin CW;Liu R;Lovell SS;Ng TI;Kort J;Mensa FJ;;
journal of hepatology 2017 Vol. 67 pp. -
382
py2017journalglecaprevir

Abstract

clinicaltrials.gov Identifiers: NCT02243280 and NCT02243293. http://www.clinicaltrials.gov/show/NCT02243280, http://www.clinicaltrials.gov/show/NCT01939197.

Citation

ID: 268471
Ref Key: py2017journalglecaprevir
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
268471
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet